Skip to main content
Journal cover image

USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF

Publication ,  Conference
Giblin, EM; Adams, K; Mi, X; Fonarow, G; Sharma, P; Albert, N; Butler, J; DeVore, A; Duffy, C; Hernandez, A; McCague, K; Spertus, JA ...
Published in: Journal of the American College of Cardiology
March 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

836 / 836

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Giblin, E. M., Adams, K., Mi, X., Fonarow, G., Sharma, P., Albert, N., … Patterson, J. H. (2019). USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. In Journal of the American College of Cardiology (Vol. 73, pp. 836–836). Elsevier BV. https://doi.org/10.1016/s0735-1097(19)31443-3
Giblin, Erika M., Kirkwood Adams, Xiaojuan Mi, Gregg Fonarow, Puza Sharma, Nancy Albert, Javed Butler, et al. “USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF.” In Journal of the American College of Cardiology, 73:836–836. Elsevier BV, 2019. https://doi.org/10.1016/s0735-1097(19)31443-3.
Giblin EM, Adams K, Mi X, Fonarow G, Sharma P, Albert N, et al. USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. In: Journal of the American College of Cardiology. Elsevier BV; 2019. p. 836–836.
Giblin, Erika M., et al. “USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF.” Journal of the American College of Cardiology, vol. 73, no. 9, Elsevier BV, 2019, pp. 836–836. Crossref, doi:10.1016/s0735-1097(19)31443-3.
Giblin EM, Adams K, Mi X, Fonarow G, Sharma P, Albert N, Butler J, DeVore A, Duffy C, Hernandez A, McCague K, Spertus JA, Thomas L, Williams F, Patterson JH. USE OF HYDRALAZINE/NITRATE, ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR AND OTHER GUIDELINE-DIRECTED MEDICAL THERAPIES AMONGST AFRICAN AMERICANS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: INSIGHTS FROM CHAMP-HF. Journal of the American College of Cardiology. Elsevier BV; 2019. p. 836–836.
Journal cover image

Published In

Journal of the American College of Cardiology

DOI

ISSN

0735-1097

Publication Date

March 2019

Volume

73

Issue

9

Start / End Page

836 / 836

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology